MANIPALHOSHealthcare

Manipal Health Enterprises Limited

Hospital · ISIN INE459N01021 · BSE 544847 · NSE EQ · FV ₹2
Last price
₹746
-0.14%today
What this company does

Manipal Health Enterprises Limited operates in Hospital, part of the Healthcare sector. It booked ₹3,091 cr of revenue in its latest quarter (Q1 FY27) and kept 7.5% of sales as profit. It is the 3rd largest of 9 Hospital companies we track, by market value.

35out of 100
Equitytale Health Score
Strained

Healthier than 35% of companies in Healthcare, on the 4 of 6 measures we could read for it. Each measure is ranked against the 136–152 companies that reported it.

Measures financial condition, not whether to buy. Learn what this score means · How this is calculated

Price momentum
neutral
RSI (14)
59

At close. Not part of the score.

Profitability & returns37

How much profit it earns on the money it employs

Balance sheet17

How much it owes, and whether earnings cover the interest

Valuation12

What today's price implies, against our models or its peers

Governance & risk100

How much of the promoters' stake is pledged, and how much they hold · highest in its sector on what we could measure

Not measurable for this company: cash quality, growth & consistency. Those pillars are left out of the score rather than counted as zero.

Is this company doing well?
not investment advice
Strengths
Makes a profit
Promoters hold 72%
No promoter shares pledged
Watch-outs
! Thin 7.5% net margin

What if I invest in MANIPALHOS?

Set a growth rate and see what a monthly SIP would add up to. Your assumption, our arithmetic.

You would put in
₹12.00 lakh
120 instalments
At 10% a year, it would become
₹20.15 lakh

The starting rate is a round number, not a view on this company — this is your assumption, and the figure above is arithmetic on it. Returns are not steady year to year, and a real holding would not grow in a straight line. We do not publish price targets or predict returns.

Key ratios · latest quarter + price
₹746 -0.14%
latest close · 2026-09-22
52-wk low ₹62534 sessions so far52-wk high ₹815
Is it cheap or expensive?
What you pay for the profits, book value and cash flow. Higher isn't automatically worse — it can signal faster growth.
P/E ratio95.2High
LowAverageHigh
How good is the business?
How much profit it earns from its money and its sales.
Net margin7.5%Decent
ThinDecentStrong
EBITDA margin25.7%Healthy
ThinDecentHealthy
Is it financially safe?
How much it owes, and whether it can comfortably cover it.
Interest cover2.1×Okay
RiskyOkayStrong ▸5×
More figures
Market cap
₹88,021 cr
Book value
EPS
₹1.96
latest quarter
Net debt
Enterprise value
EBITDA
₹3,183 cr
annualised
EBIT
₹2,434 cr
annualised
Operating margin
19.7%
Return on assets
Earnings yield
1.05%
P/S
7.12
Sales / share
₹104.8
Tax rate
22.8%
Face value
₹2
Shares
118.0 cr
Working capital
Current assets
Current liabilities
Delivery %
53.7%
Strong / safeFairWeak / riskyValuation — a level, not good/badBands are general rules of thumb, not advice.

P/E, ROE, ROCE and margins are annualised from the latest quarter; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-09-22.

Worth vs price · from the exchange filings
not investment advice
Hard to value confidentlyLow confidence
We haven't parsed this company's annual profit history yet — common for banks and insurers, whose results file in a different format — so we can't value it off earnings.

An educational model from the company's own filings, every assumption shown — not investment advice or a price target. Prices can stay above or below any model for years.

P&L · Q1 FY27 (consolidated)
Revenue from Operations₹3,091 cr
Other Income₹75 cr
Total Income₹3,165 cr
Cost of Materials₹0 cr
Purchases of Stock-in-Trade₹650 cr
Inventory Change (±)₹-24 cr
Employee Benefit Expense₹462 cr
Finance Costs₹293 cr
Depreciation & Amortisation₹187 cr
Other Expenses₹1,266 cr
Total Expenses₹2,835 cr
Exceptional Items₹-15 cr
Profit before Tax₹315 cr
Tax Expense₹72 cr
Net Profit₹243 cr
Net margin on total income7.7%
Where the money goes · Q1 FY27
% of total income
Materials + stock-in-trade₹626 cr19.9%
Employee benefit expense₹462 cr14.7%
Finance costs₹293 cr9.3%
Depreciation & amortisation₹187 cr5.9%
Other expenses₹1,266 cr40.2%
Tax expense₹72 cr2.3%
Profit for the period₹243 cr7.7%
Total income ₹3,165 cradds up to ₹100 ✓
Peer comparison
Hospital · by market value
CompanyPriceMarket capP/E
Apollo Hospitals Enterprise Limited₹8,912₹1.28 L cr55.2
Max Healthcare Institute Limited₹1,067₹1.04 L cr80.3
Manipal Health Enterprises Limitedthis company₹747₹88,145 cr95.3
Fortis Healthcare Limited₹894₹67,456 cr63.3
Global Health Limited₹1,508₹40,533 cr63.8
Aster DM Quality Care Limited₹757₹39,209 cr610.3
Narayana Hrudayalaya Ltd.₹1,897₹38,765 cr46.5
Krishna Institute of Medical Sciences Limited₹789₹33,132 cr189.6
Dr. Agarwal's Health Care Limited₹490₹15,543 cr85.7
Same industry · latest reported numbers · not a recommendation.
Who owns it · 2026-08-04
No pledge
Promoter
72.1%
FII / Foreign
3.6%
DII / Domestic
5.5%
Retail / others
18.8%
Smart-money activity
Stake changes
BoughtAxis Trustee Services ltd→ 8.86% · 11.66 cr5 Aug 26
BoughtDeutsche Bank AG Singapore Branch→ 21.78% · 28.64 cr5 Aug 26
BoughtVistra ITCL (India) Limited→ 28.06% · 36.90 cr5 Aug 26
Promoter pledges
PledgedManipal Global health Services23.21 cr · 0.00% held5 Aug 26
The named holders in this filing do not add up to the promoter total it states, so we are not presenting them as the promoter group.
How the stock has moved · adjusted for splits & bonuses
Data from primary exchange filings · analysis tool, not investment advice.